| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 21:02:45 UTC |
|---|
| Update Date | 2023-02-21 17:18:37 UTC |
|---|
| HMDB ID | HMDB0028854 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Glycylvaline |
|---|
| Description | Glycylvaline, also known as GV or gly-L-val, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Glycylvaline has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make glycylvaline a potential biomarker for the consumption of these foods. Glycylvaline is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on Glycylvaline. |
|---|
| Structure | CC(C)[C@H](NC(=O)CN)C(O)=O InChI=1S/C7H14N2O3/c1-4(2)6(7(11)12)9-5(10)3-8/h4,6H,3,8H2,1-2H3,(H,9,10)(H,11,12)/t6-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Gly-L-val | ChEBI | | Glycyl-valine | ChEBI | | GV | ChEBI | | Glycylvaline, (L)-isomer | HMDB | | Glycylvaline, (D)-isomer | HMDB | | Gly-val | HMDB | | g-V Dipeptide | HMDB | | GV Dipeptide | HMDB | | Glycine valine dipeptide | HMDB | | Glycine-valine dipeptide | HMDB | | Glycyl-L-valine | HMDB | | N-Glycyl-L-valine | HMDB | | N-Glycylvaline | HMDB | | Glycylvaline | ChEBI |
|
|---|
| Chemical Formula | C7H14N2O3 |
|---|
| Average Molecular Weight | 174.2 |
|---|
| Monoisotopic Molecular Weight | 174.100442319 |
|---|
| IUPAC Name | (2S)-2-(2-aminoacetamido)-3-methylbutanoic acid |
|---|
| Traditional Name | gly-val |
|---|
| CAS Registry Number | 1963-21-9 |
|---|
| SMILES | CC(C)[C@H](NC(=O)CN)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C7H14N2O3/c1-4(2)6(7(11)12)9-5(10)3-8/h4,6H,3,8H2,1-2H3,(H,9,10)(H,11,12)/t6-/m0/s1 |
|---|
| InChI Key | STKYPAFSDFAEPH-LURJTMIESA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- N-acyl-alpha amino acid or derivatives
- N-acyl-alpha-amino acid
- Valine or derivatives
- N-acyl-l-alpha-amino acid
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty acyl
- Fatty acid
- Amino acid or derivatives
- Secondary carboxylic acid amide
- Amino acid
- Carboxamide group
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Primary aliphatic amine
- Primary amine
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | -3.06 | Extrapolated |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M+H]+ | 137.394 | 30932474 | | DeepCCS | [M-H]- | 134.088 | 30932474 | | DeepCCS | [M-2H]- | 171.054 | 30932474 | | DeepCCS | [M+Na]+ | 146.592 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.4 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.5504 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 7.69 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 306.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 693.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 276.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 62.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 162.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 46.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 275.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 251.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 588.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 603.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 126.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 784.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 165.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 178.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 459.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 417.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 232.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Glycylvaline,1TMS,isomer #1 | CC(C)[C@H](NC(=O)CN)C(=O)O[Si](C)(C)C | 1615.3 | Semi standard non polar | 33892256 | | Glycylvaline,1TMS,isomer #2 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O | 1659.3 | Semi standard non polar | 33892256 | | Glycylvaline,1TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN)[Si](C)(C)C | 1567.5 | Semi standard non polar | 33892256 | | Glycylvaline,2TMS,isomer #1 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1705.6 | Semi standard non polar | 33892256 | | Glycylvaline,2TMS,isomer #1 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1637.3 | Standard non polar | 33892256 | | Glycylvaline,2TMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN)[Si](C)(C)C | 1579.6 | Semi standard non polar | 33892256 | | Glycylvaline,2TMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN)[Si](C)(C)C | 1650.8 | Standard non polar | 33892256 | | Glycylvaline,2TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1672.3 | Semi standard non polar | 33892256 | | Glycylvaline,2TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1665.9 | Standard non polar | 33892256 | | Glycylvaline,2TMS,isomer #4 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1851.1 | Semi standard non polar | 33892256 | | Glycylvaline,2TMS,isomer #4 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1728.6 | Standard non polar | 33892256 | | Glycylvaline,3TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1691.3 | Semi standard non polar | 33892256 | | Glycylvaline,3TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1740.9 | Standard non polar | 33892256 | | Glycylvaline,3TMS,isomer #2 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1859.6 | Semi standard non polar | 33892256 | | Glycylvaline,3TMS,isomer #2 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1792.8 | Standard non polar | 33892256 | | Glycylvaline,3TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1817.6 | Semi standard non polar | 33892256 | | Glycylvaline,3TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1813.5 | Standard non polar | 33892256 | | Glycylvaline,4TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1862.7 | Semi standard non polar | 33892256 | | Glycylvaline,4TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1878.3 | Standard non polar | 33892256 | | Glycylvaline,1TBDMS,isomer #1 | CC(C)[C@H](NC(=O)CN)C(=O)O[Si](C)(C)C(C)(C)C | 1856.5 | Semi standard non polar | 33892256 | | Glycylvaline,1TBDMS,isomer #2 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O | 1898.2 | Semi standard non polar | 33892256 | | Glycylvaline,1TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 1819.6 | Semi standard non polar | 33892256 | | Glycylvaline,2TBDMS,isomer #1 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2121.7 | Semi standard non polar | 33892256 | | Glycylvaline,2TBDMS,isomer #1 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2046.3 | Standard non polar | 33892256 | | Glycylvaline,2TBDMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 2040.2 | Semi standard non polar | 33892256 | | Glycylvaline,2TBDMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 2025.3 | Standard non polar | 33892256 | | Glycylvaline,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2127.4 | Semi standard non polar | 33892256 | | Glycylvaline,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2052.9 | Standard non polar | 33892256 | | Glycylvaline,2TBDMS,isomer #4 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2263.0 | Semi standard non polar | 33892256 | | Glycylvaline,2TBDMS,isomer #4 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2087.3 | Standard non polar | 33892256 | | Glycylvaline,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2359.6 | Semi standard non polar | 33892256 | | Glycylvaline,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2311.2 | Standard non polar | 33892256 | | Glycylvaline,3TBDMS,isomer #2 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2485.0 | Semi standard non polar | 33892256 | | Glycylvaline,3TBDMS,isomer #2 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2348.6 | Standard non polar | 33892256 | | Glycylvaline,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2481.0 | Semi standard non polar | 33892256 | | Glycylvaline,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2371.5 | Standard non polar | 33892256 | | Glycylvaline,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2712.7 | Semi standard non polar | 33892256 | | Glycylvaline,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2595.3 | Standard non polar | 33892256 |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|
| General References | - Steininger R, Karner J, Roth E, Langer K: Infusion of dipeptides as nutritional substrates for glutamine, tyrosine, and branched-chain amino acids in patients with acute pancreatitis. Metabolism. 1989 Aug;38(8 Suppl 1):78-81. [PubMed:2503685 ]
- Guardiola J, De Felice M, Klopotowski T, Iaccarino M: Mutations affecting the different transport systems for isoleucine, leucine, and valine in Escherichia coli K-12. J Bacteriol. 1974 Feb;117(2):393-405. [PubMed:4590465 ]
- De Felice M, Guardiola J, Lamberti A, Iaccarino M: Escherichia coli K-12 mutants altered in the transport systems for oligo- and dipeptides. J Bacteriol. 1973 Nov;116(2):751-6. [PubMed:4126826 ]
- Zhang CX, Tong HB, Yan CG: First soluble multipolymer MPEG-supported liquid-phase convergent synthesis of tripeptide Fmoc-GlyVal-GlyOH. J Comb Chem. 2007 Nov-Dec;9(6):924-5. Epub 2007 Oct 31. [PubMed:17970597 ]
- SHELTON DC, NUTTER WE: UPTAKE OF VALINE AND GLYCYLVALINE BY LEUCONOSTOC MESENTEROIDES. J Bacteriol. 1964 Oct;88:1175-84. [PubMed:14219035 ]
- Huckle KR, Hutson DH, Millburn P: Species differences in the metabolism of 3-phenoxybenzoic acid. Drug Metab Dispos. 1981 Jul-Aug;9(4):352-9. [PubMed:6114835 ]
- Valenkevich LN: [Clinical importance of the determination of intestinal dipeptidase and enterokinase activity in patients with chronic enteritis]. Ter Arkh. 1987;59(11):88-90. [PubMed:3481658 ]
- Kline EL, Brown CS, Umbarger HE: Effect of a leu-linked mutation on the valine sensitivity of acetohydroxy acid synthase activity in Escherichia coli. J Bacteriol. 1975 Feb;121(2):491-6. [PubMed:1089631 ]
- Nath M, Pokharia S, Eng G, Song X, Kumar A: New triorganotin(IV) derivatives of dipeptides as anti-inflammatory-antimicrobial agents. Eur J Med Chem. 2005 Mar;40(3):289-98. Epub 2005 Jan 4. [PubMed:15725498 ]
|
|---|